Biogen to Present Plegridy Data from Phase 3 Study at AAN Annual Meeting By: Benzinga via Benzinga April 29, 2014 at 07:31 AM EDT – Two-Year Data Consistent with Positive Efficacy and Safety Observed in Year One – – Additional Analyses of Year-One ADVANCE ... Read More >> Related Stocks: Biogen Idec